(CIDRAP News) Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.
(CIDRAP News) Researchers who surveyed thousands of Minnesota college students over four years found that those who got flu shots had a 30% lower rate of flu-like illness during flu seasons than those who skipped the shots, according to a report published this week.
Editor's Note: CIDRAP's Public Health Practices online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.